


Healthcare News Roundup: Oncology
HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
HSMN NewsFeed - 29 Jun 2011
iCAD’s VeraLook(R) for CT Colonography Now Available with Vital Images’ Products
iCAD’s VeraLook(R) for CT Colonography Now Available with Vital Images’ Products
HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
HSMN NewsFeed - 15 Jun 2011
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
HSMN NewsFeed - 8 Jun 2011
FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
FDA Approves Trial of Adamis Pharmaceuticals Product Candidate to Treat Prostate Cancer
HSMN NewsFeed - 3 Jun 2011
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
HSMN NewsFeed - 2 Jun 2011
Marshall Edwards Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer
Marshall Edwards Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer
HSMN NewsFeed - 1 Jun 2011
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma
HSMN NewsFeed - 31 May 2011
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
